These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 27864120
1. Epidermal growth factor receptor as an adverse survival predictor in squamous cell carcinoma of the penis. Silva Amancio AM, Cunha IW, Neves JI, Quetz JD, Carraro DM, Rocha RM, Zequi SC, Cubilla AL, da Fonseca FP, Lopes A, Cunha MD, Lima MV, Vassallo J, Guimarães GC, Soares FA. Hum Pathol; 2017 Mar; 61():97-104. PubMed ID: 27864120 [Abstract] [Full Text] [Related]
2. EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas. Nakata Y, Uzawa N, Takahashi K, Sumino J, Michikawa C, Sato H, Sonoda I, Ohyama Y, Okada N, Amagasa T. Eur J Cancer; 2011 Oct; 47(15):2364-72. PubMed ID: 21852109 [Abstract] [Full Text] [Related]
3. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR. J Clin Oncol; 2006 Sep 01; 24(25):4170-6. PubMed ID: 16943533 [Abstract] [Full Text] [Related]
4. C-MET is expressed in the majority of penile squamous cell carcinomas and correlates with polysomy-7 but is not associated with MET oncogene amplification, pertinent histopathologic parameters, or with cancer-specific survival. Gunia S, Erbersdobler A, Hakenberg OW, Koch S, May M. Pathol Res Pract; 2013 Apr 01; 209(4):215-20. PubMed ID: 23490239 [Abstract] [Full Text] [Related]
6. Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. Laurent-Puig P, Cayre A, Manceau G, Buc E, Bachet JB, Lecomte T, Rougier P, Lievre A, Landi B, Boige V, Ducreux M, Ychou M, Bibeau F, Bouché O, Reid J, Stone S, Penault-Llorca F. J Clin Oncol; 2009 Dec 10; 27(35):5924-30. PubMed ID: 19884556 [Abstract] [Full Text] [Related]
7. Epidermal growth factor receptor-related tumor markers and clinical outcomes with erlotinib in non-small cell lung cancer: an analysis of patients from german centers in the TRUST study. Schneider CP, Heigener D, Schott-von-Römer K, Gütz S, Laack E, Digel W, Guschall WR, Franke A, Bodenstein H, Schmidtgen C, Reck M. J Thorac Oncol; 2008 Dec 10; 3(12):1446-53. PubMed ID: 19057271 [Abstract] [Full Text] [Related]